Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263029
Status:
COMPLETED
Last Update Posted:
2009-09-18
First Post:
2005-12-06
Brief Title:
Preoperative Radiotherapy Oxaliplatin Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Pre-operative Radiotherapy Oxaliplatin Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer PROCTFUL
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROCTFUL
Brief Summary:
The purpose of this phase II trial is to determine the efficacy and safety of the combination of oxaliplatin capecitabine and radiotherapy as preoperative therapy in locally advanced cancers of the rectum
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None